Röthl Martina Anna
Graz, Styria, 8036, Austria
Location status: Recruiting
Location contact
Marianne Leitsmann, Prof. Dr.
CONTACT
Marianne Leitsmann, Prof. Dr.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06397287
All patients undergoing urological surgery or treatment should receive standardized questionnaires on quality of life, satisfaction, pain and physical recovery. Indication-specific, individual pathways are set up, for example, for patients with localized prostate cancer, benign prostate enlargement, bladder dysfunction or erectile dysfunction. In combination with the clinical data, the PROM data should help to improve the quality of the results and, if necessary, adapt treatment pathways to patient needs.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Graz, Styria, 8036, Austria
Location status: Recruiting
Marianne Leitsmann, Prof. Dr.
CONTACT
Marianne Leitsmann, Prof. Dr.
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients undergoing urological surgery or treatment receive standardized questionnaires on quality of life, satisfaction, pain and physical recovery. Indication-specific, individual pathways are set up,
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment EPIC-26 score: max 100 points; greater values indicate improved functional outcomes
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment. PROMIS-10 max 50 points; greater values indicate healthier status
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment. BPI: max. 11 points; greater values indicate worse outcome
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment. IEF: 0-25 points; greater values indicate better ercetile function
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment. IPSS: score 0-35; greater values indicates increased symptom severity
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment. OAB-SF: score 0 - 16; score with greater values indicates increased symptom severity
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment. ICIQ-UI: score 0-21; greater values indicate worse urinary incontinence
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Electronically recorded Patient Reported Outcomes (PROs) are captured for each patient depending on the condition and surgery/treatment. NHS-CSI: 0-43 points; greater values indicate worse outcomes
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Clinical parameters are captured for each patient undergoing sugery
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Clinical parameters are captured for each patient undergoing sugery
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Clinical parameters are captured for each patient undergoing sugery
Time frame: Data collection/follow-up: day - 1 before surgery, 2 to 10 days host surgery, after 3, 6, 12 months, annually 2 to 10 years
Clinical parameters are captured for each patient undergoing sugery
Time frame: during surgery, surgery time depending on the disease (30 minutes to 4 hours)
Perioperative data are captured for each patient undergoing sugery
Time frame: during surgery, surgery time depending on the disease (30 minutes to 4 hours)
Perioperative data are captured for each patient undergoing sugery
Time frame: during surgery, surgery time depending on the disease (30 minutes to 4 hours)
Perioperative data are captured for each patient undergoing sugery
Time frame: depending on the disease and following surgery (1 to 10 days)
Perioperative data are captured for each patient undergoing sugery
Medical University of Graz
Other
Standardized Collection of Patient Reported Outcomes (PROs) in Everyday Clinical Practice
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04982822
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Taipei, Outside U.S./Canada, Taiwan
View Trial DetailsNCT03572348
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Syracuse, New York, United States
View Trial DetailsNCT04770259
Anesthesia, Digestive Disease
Santiago, Santiago Metropolitan, Chile
View Trial DetailsNCT05222659
Blood Glucose, High, Female Urogenital Diseases
Kansas City, Kansas, United States
View Trial Details